News Archive

Making clinical tools from basic research knowledge is a practice Novartis and FMI researchers pursue. Read how they want to help retinitis pigmentosa patients to see the light.

Hundreds of millions of people worldwide await treatments for rare diseases.

Researchers at Novartis are combining modern techniques with an old approach to drug discovery and getting surprising results.

Why are some sickle cell disease patients protected from the disease? Learn about our biomedical research in the field.

In October 2013, we created a new, full-time position to lead our CR efforts. Juergen Brokatzky-Geiger, formerly Global Head of Human Resources and a member of the Executive Committee, took on this role effective in February 2014.

Ask Alan Frohman how he found out that he had glaucoma, and he'll quickly tell you that there were no warning signs.

When a middle-aged firefighter and active Boy Scout leader in the Midwestern United States lost his hearing a few years ago, he also faced the loss of his livelihood.

Cataracts are a serious but common eye condition affecting more than 20 million worldwide. A patient in Brazil tells her story.